Sharda Cropchem Q4 FY26 PAT Jumps 57% to INR 319 Cr

Sharda Cropchem reported its best-ever annual performance with Q4 FY26 PAT surging 57% YoY to INR 319 crores and full-year PAT up 124% to INR 681 crores.
The company provided FY27 revenue growth guidance of 10-15% and expects to maintain gross margins around 35% and EBITDA margins of 18-20%.
Management highlighted strong volume growth in Europe and LATAM, with total product registrations reaching 3,011 and another 1,004 applications in the pipeline.
The board recommended a final dividend of INR 9 per share, bringing the total FY26 dividend to INR 15 per equity share.